Alkylaminoalkylamine and ether compounds, processes and intermediates for their preparation, and medicaments containing them

A compound corresponding to the formula I ##STR58## wherein n represents 2-5,

• m represents 2-6,
• R.sub.1 denotes hydrogen or lower alkyl,
• R.sub.2 represents an OR.sup.4 group in which R.sup.4 denotes a lower alkyl, phenyl or phenyl-lower alkyl group which is optionally substituted in the phenyl ring by 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, halogen and lower alkylenedioxy, or
• R.sup.2 represents a ##STR59## group in which R.sup.5 denotes hydrogen, lower alkyl or a phenyl or phenyl-lower alkyl group which is optionally substituted in the phenyl ring by to 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, halogen, trifluoromethyl and lower alkylenedioxy, and
• R.sup.6 denotes hydrogen, lower alkyl or a phenyl or phenyl-lower alkyl group which is optionally substituted in the phenyl ring by 1 to 3 substituents selected from the group consisting of lower alkyl, lower alkoxy, halogen, trifluoromethyl and lower alkylenedioxy, or
• R.sup.5 and R.sup.6, together with the nitrogen atom to which they are bonded, represent a saturated 5- or 6-membered heterocycle, which can optionally contain a second hetero atom from the group of oxygen and N-R.sup.7, in which R.sup.7 denotes lower alkyl or benzyl,
• R.sup.3 represents a saturated monocyclic or bicyclic terpene hydrocarbon radical having 10 carbon atoms or a bicyclic hydrocarbon radical having 11 carbon atoms, of the formula b ##STR60## and Z represents oxygen or, if R.sup.3 denotes a radical of the formula b, Z may also represent sulfur,
• and physiologically acceptable acid addition salts thereof.